NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.73
-0.56 (-3.44%)
At close: Aug 5, 2026, 4:00 PM EDT
15.84
+0.11 (0.70%)
After-hours: Aug 5, 2026, 7:46 PM EDT
NeoGenomics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 145.54 | 159.62 | 367.01 | 342.49 | 263.18 | 316.83 |
Short-Term Investments | - | - | 19.83 | 72.72 | 174.81 | 198.56 |
Cash & Short-Term Investments | 145.54 | 159.62 | 386.84 | 415.2 | 437.99 | 515.39 |
Cash Growth | -11.09% | -58.74% | -6.83% | -5.20% | -15.02% | 73.97% |
Accounts Receivable | 175.41 | 159.24 | 150.54 | 131.23 | 119.71 | 112.13 |
Inventory | 27.14 | 28.57 | 26.75 | 24.16 | 24.28 | 23.4 |
Other Current Assets | 33.4 | 28.86 | 31.89 | 26.23 | 23.31 | 30.59 |
Total Current Assets | 381.48 | 376.29 | 596.02 | 596.81 | 605.29 | 681.51 |
Net Property, Plant & Equipment | 166.2 | 163.28 | 173.69 | 183.78 | 198.61 | 211.66 |
Other Intangible Assets | 271.26 | 286.53 | 339.68 | 373.13 | 408.26 | 442.33 |
Goodwill | 524 | 524.34 | 522.77 | 522.77 | 522.77 | 527.12 |
Other Long-Term Assets | 9.31 | 9.39 | 5.89 | 4.74 | 5.11 | 7.17 |
Total Assets | 1,352 | 1,360 | 1,638 | 1,681 | 1,740 | 1,870 |
Accounts Payable | 20.95 | 23.09 | 21.61 | 20.33 | 20.51 | 17.92 |
Accrued Expenses | 79.31 | 59.58 | 75.07 | 68.23 | 55.21 | 56.1 |
Current Portion of Long-Term Debt | - | - | 200.78 | - | - | - |
Current Portion of Leases | 5.43 | 4.78 | 3.38 | 5.61 | 6.65 | 8.02 |
Unearned Revenue | 0.19 | 0.85 | 0.41 | 2.13 | 7.56 | 5.19 |
Total Current Liabilities | 105.88 | 88.3 | 301.24 | 96.3 | 89.93 | 87.23 |
Long-Term Debt | 374.24 | 341.86 | 340.34 | 538.2 | 535.32 | 532.48 |
Long-Term Leases | 68.7 | 62.82 | 60.84 | 67.87 | 68.95 | 72.29 |
Other Long-Term Liabilities | 17.69 | 30.29 | 33.28 | 37.32 | 47.81 | 69.5 |
Total Long-Term Liabilities | 460.63 | 434.97 | 434.46 | 643.39 | 652.08 | 674.27 |
Total Liabilities | 566.51 | 523.27 | 735.7 | 739.69 | 742.01 | 761.5 |
Common Stock | 0.13 | 0.13 | 0.13 | 0.13 | 0 | 0.12 |
Treasury Stock | -25 | - | - | - | - | - |
Additional Paid-in Capital | 1,259 | 1,270 | 1,228 | 1,190 | 1,161 | 1,124 |
Accumulated Other Comprehensive Income | 0 | 0 | -0.21 | -1.67 | -3.9 | -0.64 |
Retained Earnings | -448.67 | -433.81 | -325.78 | -247.06 | -159.09 | -14.84 |
Total Common Shareholders' Equity | 785.73 | 836.56 | 902.34 | 941.54 | 997.9 | 1,108 |
Shareholders' Equity | 785.73 | 836.56 | 902.34 | 941.54 | 998.02 | 1,108 |
Total Liabilities & Equity | 1,352 | 1,360 | 1,638 | 1,681 | 1,740 | 1,870 |
Total Debt | 448.37 | 409.46 | 605.33 | 611.68 | 610.93 | 612.79 |
Net Cash (Debt) | -302.83 | -249.84 | -218.49 | -196.48 | -172.94 | -97.4 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.34 | -1.95 | -1.73 | -1.57 | -1.39 | -0.81 |
Book Value | 785.73 | 836.56 | 902.34 | 941.54 | 997.9 | 1,108 |
Book Value Per Share | 6.08 | 6.53 | 7.12 | 7.50 | 8.03 | 9.24 |
Tangible Book Value | -9.53 | 25.69 | 39.89 | 45.64 | 66.87 | 138.84 |
Tangible Book Value Per Share | -0.07 | 0.20 | 0.31 | 0.36 | 0.54 | 1.16 |